Kyung Dong Pharmaceutical Co., Ltd. (KOSDAQ:011040)
South Korea flag South Korea · Delayed Price · Currency is KRW
4,900.00
-60.00 (-1.21%)
At close: Oct 23, 2026

Kyung Dong Pharmaceutical Financials Overview

Millions KRW. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
201,120196,273193,936162,674182,718177,611
Revenue Growth
3.46%1.21%19.22%-10.97%2.88%2.18%
Gross Profit
122,115117,101114,36589,34495,91098,082
Operating Income
11,7727,6662,624-24,9558,31215,758
Net Income
17,8318,5295,470-20,70812,16112,672
Earnings Per Share
647.56314.71202.73-763.17446.96460.42
EPS Growth
331.24%55.24%---2.92%-9.33%

Revenue by Segment

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Rental Sector
4,1954,1124,0573,6213,0232,930
Others
5,6036,7397,9527,84113,84312,465
Pharmaceutical Sector
193,104187,494184,161153,262167,073163,887
Adjustments and Removal
-1,782-2,072-2,233-2,050-1,221-1,672
Total
201,120196,273193,936162,674182,718177,611

Cash & Debt

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
27,68146,99830,91332,07545,12850,043
Total Debt
25,69245,44338,67715,37326,8694,329
Net Cash (Debt)
1,9891,554-7,76416,70118,25945,714
Net Cash Growth
----8.53%-60.06%-23.28%
Net Cash Per Share
72.1757.28-287.77615.52671.071660.97

Cash Flow & CapEx

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
20,66516,934-8,074-31.94-1,07512,422
Capital Expenditures
-16,059-18,394-7,618-6,290-10,574-3,926
Free Cash Flow
4,606-1,460-15,692-6,322-11,6498,496
Free Cash Flow Growth
-55.00%-----

Margins

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
60.72%59.66%58.97%54.92%52.49%55.22%
Operating Margin
5.85%3.91%1.35%-15.34%4.55%8.87%
Pretax Margin
10.56%4.65%2.69%-11.37%9.82%10.38%
Profit Margin
8.87%4.35%2.82%-12.73%6.66%7.13%
FCF Margin
2.29%-0.74%-8.09%-3.89%-6.38%4.78%

Dividends

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingOct '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Dividend Per Share
300.000300.000--400.000500.000
Dividend Per Share Growth
0%----20.00%0%
Dividend Yield
6.12%5.57%--5.08%4.34%

Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingOct '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PE Ratio
7.5718.4530.19-17.5624.74
Forward PE
-12.1112.1112.1112.1112.11
P/FCF Ratio
31.17----36.90
PS Ratio
0.710.800.851.101.171.77